The perineuronal net (PNN) surrounds neurons in the central nervous system and is thought to regulate developmental plasticity. A few studies have shown an involvement of the PNN in hippocampal plasticity and memory storage in adult animals. In addition to the hippocampus, plasticity in the medial prefrontal cortex (mPFC) has been demonstrated to be critical for the storage of long-term memory, particularly memories for temporally separated events. In the present study, we examined the role of PNN in the acquisition and retention of memories for trace (in which the conditioned and unconditioned stimuli are temporally separated) and delayed (in which the conditioned and unconditioned stimuli overlap) fear conditioning in both the hippocampus and the mPFC. Consistent with a role for the hippocampus in memory storage in both delayed and trace fear conditioning, removal of hippocampal PNN disrupted contextual and trace fear memory. Disruption of the PNN in the mPFC impaired long-term trace and conditioned stimulus (CS)-elicited fear memory in the trace fear conditioning task. Interestingly, CS-elicited fear memory was also impaired when a delayed fear conditioning paradigm was used. These findings further support a role for the PNN in neural plasticity and implicate PNN-regulated plasticity in neocortical memory storage.
The extracellular matrix (ECM) that surrounds neurons (also referred to as the perineuronal net or PNN) has been proposed to play an important role in synaptic stabilization and plasticity during development (Pizzorusso et al. 2002 (Pizzorusso et al. , 2006 Nowicka et al. 2009 ). The backbone of the PNN is hyaluronic acid (HA; also known as a hyaluronan or hyaluronate) to which chondroitin sulfate proteoglycans (CSPGs) are covalently linked. It has been reported that the primary sensory and motor areas contain considerably more PNN than secondary or higher order association areas in the adult brain (Hockfield and McKay 1983; Hendry et al. 1988; McGuire et al. 1989; Bruckner et al. 1994 Bruckner et al. , 1999 Bruckner et al. , 2008 Hausen et al. 1996) . As secondary and association regions are thought to be more plastic than primary sensory and motor areas, it has been suggested that the PNN may also play a role in regulating synaptic plasticity in the adult brain.
A role for the PNN in learning and memory in the adult brain is beginning to emerge (Gogolla et al. 2009; Kochlamazashvili et al. 2010) . For example, enzymatic degradation of CSPGs, or removal of the ECM protein tenascin-R, reduces long-term potentiation (LTP) and long-term depression (LTD) in hippocampal slice preparations (Saghatelyan et al. 2000; Bukalo et al. 2001) . Furthermore, degradation of HA in the hippocampus impairs retention of contextual fear memory (Kochlamazashvili et al. 2010) . Although these and other studies have begun to identify a role for hippocampal PNN, the role of the PNN in memory storage in the neocortex, where it is found to be primarily associated with inhibitory neurons (Alpár et al. 2006) , has yet to be fully elucidated.
Previous studies have shown that the rodent medial prefrontal cortex (mPFC), a higher order association area in the neocortex, is necessary for the acquisition of trace conditioning (Kronforst-Collins and Disterhoft 1998; Weible et al. 2000; McLaughlin et al. 2002) . For example, Kronforst-Collins and Disterhoft (1998) demonstrated that lesions of the rabbit mPFC impair eyeblink conditioning when the conditioned and unconditioned stimuli were separated by a trace period, but not when the stimuli overlapped as occurs during delayed conditioning. In addition to memory acquisition, plasticity in both mPFC and the hippocampus is required for the storage of trace fear memory (McLaughlin et al. 2002; Dash et al. 2004) . We therefore used a combination of chondroitinase plus hyaluronidase to degrade the PNN in the mPFC or dorsal hippocampus (dHPC), and investigated the consequences of its removal in the acquisition and retention of trace and delayed fear.
Results

Intra-parenchymal infusion of chondroitinase plus hyaluronidase disrupts the perineuronal net
Prior to initiation of learning and memory testing, we examined if the combination of chondroitinase + hyaluronidase would result in removal of the PNN. A group of rats (n ¼ 4) was given targeted infusions of chondroitinase + hyaluronidase into one hippocampus, while an equal volume of vehicle was simultaneously infused into the contralateral hippocampus. Animals were killed 3 h later and 40-mm thick brain sections were prepared on a cryostat for immunohistochemical examination of CSPGs using biotinylated Wisteria floribunda agglutinin (WFA). Biotinylated WFA is a plant lectin that binds to CSPGs and can be visualized using fluorescently labeled streptavidin (Hartig et al. 1992; Gogolla et al. 2009 ). In vehicle-treated hippocampi, we observed a greater presence of PNN in the CA3/CA2 subfields, a moderate amount in the dentate gyrus, and a near absence of net in the CA1 subfield (Fig. 1A) . Chondroitinase + hyaluronidase infusion resulted in a loss of WFA binding throughout the dHPC. Combined treatment did not alter NeuN immunoreactivity, indicating that the loss of PNN did not cause overt neuronal loss (Fig. 1B) , nor did it affect parvalbumin immunoreactivity, a marker for inhibitory neurons (Fig. 1C) .
We next tested the efficacy of chondroitinase + hyaluronidase to remove mPFC PNN by infusing these enzymes into the ipsilateral mPFC and an equal volume of vehicle was simultaneously infused into the contralateral mPFC. Figure 1D shows that in the vehicle-infused side, PNNs were predominately found in the deep cortical layers (layers IV-VI) of the mPFC, with limited staining observed in layers II and III. Enzyme infusion effectively removed the PNNs as indicated by the loss of WFA immunoreactivity at 3-h post-infusion. As seen in the hippocampus, infusions had no overt effect on mPFC neuronal survival as indicated by NeuN (Fig. 1E ) and parvalbumin immunohistochemistry (Fig. 1F) . Consistent with that reported for other neocortical areas, the high magnification images shown in Figure 1G indicate that the PNN in the mPFC exists as a network and is more intense surrounding parvalbumin-positive inhibitory neurons.
Intra-hippocampal chondroitinase + hyaluronidase infusion impairs long-term contextual fear memory Rats received bilateral intra-hippocampal infusions of chondroitinase + hyaluronidase (n ¼ 6) or vehicle (n ¼ 8) 3 h prior to fear conditioning training ( Fig. 2A) . Figure 2B illustrates that removal of the PNN in the hippocampus prior to training did not influence acquisition of delayed fear (F (1,13) ¼ 0.60, P ¼ 0.45). When tested 48 h later, contextual (vehicle, 62.00% + 6.39%; chondroitinase + hyaluronidase, 16.33% + 5.21%, P ¼ 0.001) (Fig. 2C) memory was impaired. Further analysis revealed that animals treated with chondroitinase + hyaluronidase froze significantly less than vehicle-treated controls throughout the entire 3-min contextual testing period (F (1,12) ¼ 29.39, P ¼ 0.001) (Fig. 2D ).
Intra-hippocampal chondroitinase + hyaluronidase infusion impairs long-term fear memory for trace fear As hippocampal plasticity is also required for trace fear memory storage, we examined the consequences of PNN disruption using this paradigm. Groups of animals received bilateral infusions of either chondroitinase + hyaluronidase (n ¼ 10) or vehicle (n ¼ 9), then 3 h later were trained in the trace fear conditioning task (Fig. 3A) . Both groups learned the task, as demonstrated by increased freezing during the tone (F (6,102) ¼ 45.664, P , 0.001) ( Fig. 3B ) and trace period (F (6,102) ¼ 56.442, P , 0.001) (Fig. 3C ). However, there was no group difference in acquisition (P . 0.05). As observed in delayed fear conditioning, long-term contextual memory was significantly impaired in the chondroitinase + hyaluronidase-treated rats compared to vehicle-treated controls when tested 48 h later (vehicle, 29.44% + 3.47%; chondroitinase + hyaluronidase, 7.67% + 2.49%, P , 0.001) (Fig. 3D ). When tested for CS and trace memory, animals with disrupted hippocampal PNN demonstrated significantly less freezing during both the presentation of the CS (vehicle, 42.56% + 2.69%; chondroitinase + hyaluronidase, 19.98% + 2.37%, P , 0.001) and during the trace period (vehicle, 38.06% + 1.99%; chondroitinase + hyaluronidase, 13.75% + 3.08%, P , 0.001) (Fig. 3E) . Following the completion of the memory testing, animals were euthanized and the location of the infusions sites was determined by cresyl violet staining of brain sections (Fig. 3F ). All animals in the delay and trace fear studies had infusion sites within the dHPC (Fig. 3F) .
Removal of mPFC PNN impairs the retention of long-term trace fear
In order to test the consequence of removing the PNNs in the mPFC on trace fear conditioning, animals received bilateral infusions of chondroitinase + hyaluronidase (n ¼ 12) or vehicle (n ¼ 12). Three hours later, rats were trained in the trace fear conditioning task (Fig. 4A ). Although the rate at which the enzyme-infused animals acquired CS-elicited fear was significantly slower than that observed in vehicle-treated animals (F (1,22) ¼ 8.873, P ¼ 0.007) (Fig. 4B) , both groups demonstrated equivalent freezing behaviors by the end of training. No difference was observed in the rate of learning when freezing during the trace period was assessed (F (1,22) ¼ 1.733, P ¼ 0.202) (Fig. 4C) . Figure 4D shows that removal of the PNN in the mPFC had no effect on long-term contextual fear memory (vehicle, 29.5% + 4.67%; chondroitinase + hyaluronidase, 22.33% + 6.02%, P ¼ 0.357). When tested for CS-elicited fear, the chondroitinase + hyaluronidase-treated rats froze significantly less during the tone presentations than did vehicle-treated controls (vehicle, 26.40% + 4.37%; chondroitinase + hyaluronidase, 13.96% + 2.26%, P ¼ 0.019). Freezing during the trace period was also significantly reduced following mPFC PNN removal (vehicle, 39.79% + 6.69%; chondroitinase + hyaluronidase, 19.46% + 4.64%, P ¼ 0.021) (Fig. 4E) . This difference was specific to the trace period, as no difference was observed when freezing was measured 30 sec immediately prior to CS presentation (pre-CS) (P . 0.05) (Fig. 4E) . When the amount of freezing during the trace period was compared to the amount of freezing during the 30-sec pre-CS period within a group, only vehicle-treated animals demonstrated an increased amount of freezing during the trace period (P , 0.05). This suggests that while vehicle-treated animals were able to distinguish between the trace period and pre-CS period, enzyme-treated animals failed to remember the significance of the trace period.
Removal of mPFC PNN impairs cue-specific fear following delayed conditioning
Although previous lesion studies have demonstrated that the mPFC is not required for delayed conditioning, a number of studies have found increased neuronal activity in the mPFC during the presentation of the CS (Baeg et al. 2001; Gilmartin and McEchron As we observed that PNN removal impaired cue-elicited fear following trace conditioning, we questioned if a similar impairment would be seen following delayed fear conditioning. Animals received either bilateral infusions of both chondroitinase + hyaluronidase (n ¼ 10) or vehicle (n ¼ 10) into the mPFC and were trained in delay fear conditioning 3 h later (Fig. 5A) . Removal of the mPFC PNNs had no effect on acquisition as both groups expressed fear during the tone presentations (F (1,18) ¼ 0.381, P ¼ 0.545) (Fig. 5B) . Although intra-mPFC infusions of chondroitinase + hyaluronidase had no effect on contextual memory (vehicle, 52.50% + 5.15; chondroitinase + hyaluronidase, 53.30% + 5.13, P ¼ 0.914), long-term memory for the CS was disrupted in enzyme-treated animals (vehicle, 63.20% + 9.03; chondroitinase + hyaluronidase, 15.80 + 3.24, P , 0.001) (Fig. 5C ). Further analysis of freezing using 30-sec bins revealed that the treated animals froze significantly less throughout the entire 3 min of testing (Fig. 5D) . Following the completion of behavioral testing, rats were euthanized and injection sites were examined on cresyl violet stained brain sections. All of the infusions were located within the mPFC for both the trace and delay fear behavioral studies (Fig. 5E) .
Discussion
In the present study, we examined the role of hippocampal and mPFC PNN in long-term memory storage using both delayed and trace fear conditioning paradigms. Our results revealed three key findings: (1) disruption of the PNN in the hippocampus, but not in the mPFC, impairs context-specific memory, (2) trace fear memory is impaired by removal of PNN in either the hippocampus or in the mPFC, and (3) PNN removal in the mPFC disrupts CS-elicited fear memory in both trace and delayed fear conditioning.
Prior studies have shown that the sensory and motor cortices have high levels of PNN whereas higher association areas have relatively less PNN expression (Hockfield and McKay 1983; Hendry et al. 1988; McGuire et al. 1989; Bruckner et al. 1994 Bruckner et al. , 1999 Bruckner et al. , 2008 Hausen et al. 1996) . As it is thought that PNNs stabilize synaptic connectivity, it has been suggested that areas with high PNN levels may be less plastic (Gati et al. 2010; Bartus et al. 2012; McRae and Porter 2012) . We observed that the CA3 subfield of the hippocampus had the greatest amount of WFA staining, with less intense staining observed in other hippocampal subfields, particularly CA1. These findings are in agreement with previous reports by Bruckner et al. (2003) , and suggest that the CA1 subfield of the hippocampus can readily undergo plastic changes during training in order to store learned information (Tsien et al. 1996; Blum et al. 1999) .
Previous research has shown that lesions of the hippocampus impair contextual fear in both delayed and trace fear conditioning tasks (Weiss et al. 1999; Esclassan et al. 2009) . Although it has been demonstrated that infusion of hyaluronidase into the hippocampus impairs contextual fear memory (Kochlamazashvili et al. 2010) , the consequences of PNN disruption on trace fear memory had not been examined. Our results show that disruption of the PNN in the hippocampus does not influence the acquisition of trace fear conditioning, but impairs the memory for both the context in which the training took place, as well as for the trace period. Although the present study cannot delineate the contribution of the individual hippocampal subfields to the memory impairment we observed, recent electrophysiological recordings from the CA1 subfield have shown that during recall of a trace fear memory there is increased neural activity that peaks prior to when the shock would be expected (Chen et al. 2009; Song et al. 2012) . Further, this increase in neuronal activity is observed when the animal is placed back in the original training context in the absence of the tone (Chen et al. 2009 ). Taken together, these data suggest that although the CA1 subfield has proportionally less PNN than other areas of the hippocampus, disruption of the PNN in this subfield likely contributed to the memory impairments we observed.
In addition to the hippocampus, the mPFC has been implicated in trace fear conditioning (Kronforst-Collins and Disterhoft 1998; Weible et al. 2000; McLaughlin et al. 2002) . For example, McLaughlin et al. (2002) found that lesions of the mPFC disrupt trace eyeblink conditioning, but had no impact upon delay conditioning. Furthermore, studies have shown that the mPFC undergoes plastic changes at the time of training and that these changes are required for trace memory storage . Consistent with these reports, we found that preconditioning disruption of the PNN in the mPFC impairs longterm trace fear memory. Interestingly, we also observed that the acquisition of cue-elicited fear was impaired by PNN removal, further supporting a role for the mPFC in CS processing. However, how acquisition was influenced by PNN removal is not yet known. When we evaluated the distribution of PNNs in the mPFC using WFA staining, we observed that the PNN exists as a network with higher staining surrounding parvalbumin-positive inhibitory neurons (Fig. 1G ). This suggests that PNN removal may impact GABAergic activity and plasticity, possibly giving rise to the acquisition effects we observed. Consistent with this, it has been reported that removal of PNN increases the excitability of inhibitory basket neurons (Dityatev et al. 2007 ).
In addition to influencing acquisition, we found that PNN removal in the mPFC impaired CS-elicited fear memory following both trace and delay conditioning paradigms. Although previous studies have reported that lesions of the mPFC do not disrupt delayed fear conditioning (Gewirtz et al. 1997; McLaughlin et al. 2002) , recent electrophysiological recordings have shown that the activity of subsets of neurons within the mPFC increases in response to cue presentation during acquisition and recall of conditioned fear (Baeg et al. 2001; Gilmartin and McEchron 2005; Laviolette et al. 2005; Burgos-Robles et al. 2009 ). Our finding that PNN removal impairs cue-elicited fear memory further implicates this structure in the storage of cue-elicited fear. In addition, these findings also show that information storage occurs both in the hippocampus and in the mPFC as a direct result of training, and that the stored information in both these structures is required for the appropriate behavioral response to fearful stimuli.
Materials and Methods
Materials
Male Long Evans rats (250-275 g) were purchased from Harlan (Indianapolis). Protease free ABC chondroitinase was purchased from Seikagaku Corporation and hyaluronidase was bought from Calibochem. The NeuN antibody was purchased from Millipore, WFA was obtained from Sigma Aldrich, and parvalbumin antibody was purchased from Thermo Fisher Scientific.
Drug preparation and administration
All protocols involving the use of animals are in compliance with NIH's Guide for The Care and Use of Laboratory Animals and approved by The Institutional Animal Care and Use Committee. Rats were anesthetized using 4% isoflurane with a 2:1 N 2 O:O 2 mixture and then maintained with a 2% isoflurane/2:1 N 2 O:O 2 mixture via a facemask. Bilateral guide cannulae, aimed at the dHPC (AP -3.3 mm, L + 2.0 mm from bregma, and V 22.0 mm from the dura) or prefrontal cortex (PFC) (AP +3.2 mm, L + 0.8 mm from bregma, and V 22.5 mm from the dura), were implanted. The rats were then allowed to recover in their home cages for 10-12 d. For intra-hippocampal infusions, the injection cannulae extended 1.75 mm beyond the tips of the guides, yielding a total depth of 3.75 mm below the dura. For intra-mPFC infusions, the injection cannulae extended 1.5 mm beyond the tips of the guides, yielding a total depth of 4.0 mm below the dura. A working solution of ABC chondroitinase was prepared by dissolving 2 U in sterile saline for a final injection concentration of 25 U/mL. Hyaluronidase was dissolved in sterile saline for a final concentration of 0.70 mg/mL. The chondroitinase + hyaluronidase working solution was prepared as follows. The hyaluronidase was initially diluted in sterile saline then added to 2 U chondroitinase. All infusions (1 mL/hippocampus or 0.7 mL/mPFC of either drug or vehicle) were performed in freely moving animals at a rate of 0.25 mL/min using a dual syringe infusion pump (Stoelting) followed by a 2-min waiting period. The use of these concentrations was guided by previous studies using these enzymes to disrupt HA and CSPG, respectively (Tona and Bignami 1993; Nakamura et al. 2009 ).
Immunohistochemistry
The influence of chondroitinase and/or hyaluronidase infusions on the disruption of the PNN was assessed in a separate group of rats than those used for behavioral testing. Rats were anesthetized as previously stated and chondroitinase and/or hyaluronidase was infused into one hippocampus (or mPFC), while an equal volume of vehicle was simultaneously infused into the contralateral hippocampus (or mPFC) of the same animal. The same dose of chondroitinase and/or hyaluronidase as used for the behavioral studies was utilized. Three hours later, rats were deeply anesthetized with sodium pentobarbital (100 mg/kg) and transcardially perfused with PBS followed by 4% paraformaldehyde. Brains were removed, cryoprotected in 30% sucrose (in PBS), and sectioned into 40-mm thick slices using a cryostat. Free-floating slices were incubated overnight in primary antibodies (0.5-1.0 mg/mL) containing 0.1% triton X-100 in PBS containing 2% BSA and 2% normal goat serum. After extensive washing, immunoreactivity was detected using species-specific secondary antibodies coupled to Alexafluors. Strepavidin conjugated Alexafluros was used for WFA staining. Sections were then mounted on slides and viewed using a Zeiss Axiovert microscope. Photomicrographs were taken of the prefrontal cortex and the dHPC.
Fear conditioning
All behavioral tests were performed by an investigator who was blind to the treatment groups. For delay fear conditioning, animals were placed in the training context (Habitest Unit, Coulbourne Instruments) and given a 120-sec familiarization period. Fear conditioning trials began with a 10-sec tone (CS) which co-terminated with a 2-sec 1.0-mA foot shock (US). Animals received three CS -US paired training trials, separated by a 120-sec inter-trial interval (ITI). Forty-eight hours following fear conditioning training, each animal was tested for long-term contextual fear memory by placing it back in the original training chamber and monitoring freezing behavior every 2 sec for a total of 3 min. In order to test long-term memory for the CS, animals were placed in a novel chamber for a 120-sec habituation period, followed by a single 3-min tone presentation. Animals were monitored for freezing behavior during the exploratory period in the novel chamber as well as during the 3-min cue presentation.
For trace fear conditioning, rats were placed in the training context for 120 sec (Habitest Unit, Coulbourne Instruments). Rats were then given seven training trials. Each trial consisted of a 10-sec tone followed by a 20-sec trace period. At the end of the trace period, animals received a 0.5-sec, 0.5-mA foot shock. Each trial was separated by an ITI that varied from 1 to 4 min in length. This was done in order to prevent the ITI from serving as a cue for the presentation of the US. The amount of freezing was measured 30 sec prior to the presentation of the tone (pre-CS period), during the presentation of the tone (CS period), and during the trace period (trace period freezing). Rats were tested for contextual and cue memory 48 h following training. During contextual fear memory testing, rats were placed back in the original training context for 3 min and freezing behavior was monitored. Animals were then placed in a novel context for 120 sec and given four presentations of the CS without the US in order to test for the memory. Freezing behavior during the tone and trace period was measured. Freezing behavior is defined as the absence of all movement, excluding movement caused by respiration, and is used as a behavioral means of measuring fear.
Verification of cannula placement
Following the completion of behavioral testing, rats were euthanized by a CO 2 overdose. The tissue was then removed and postfixed in 4% paraformaldehyde for 24 -48 h and then cryoprotected in 30% sucrose. The tissue was sliced into 40-mm sections and sections containing the infusion site were mounted onto slides, stained with cresyl violet, and subsequently analyzed for correct placement of the cannula.
Statistical analysis
For evaluation of behavioral data, repeated measures analyses of variance (two-way or one-way as appropriate) were used. A Holm-Sidak method for multiple comparisons post-hoc tests was used to determine data points with significant differences. Student's t-tests were utilized to determine statistical differences between control and experimental groups during retention testing. Data were considered significant at P ≤ 0.05 and presented as mean + standard error of the mean.
